Ticker Details
Vir Biotechnology, Inc.
IPO Date:	October 11, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.65B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.90 | 3.66%
Avg Daily Range (30 D):	$0.27 | 2.90%
Avg Daily Range (90 D):	$0.28 | 2.97%

Institutional Daily Volume
Avg Daily Volume:	1.1M
Avg Daily Volume (30 D):	1.24M
Avg Daily Volume (90 D):	1.37M

Trade Size
Avg Trade Size (Sh.):	83
Avg Trade Size (Sh.) (30 D):	76
Avg Trade Size (Sh.) (90 D):	74

Institutional Trades
Total Institutional Trades:	3,357
Avg Institutional Trade:	$2.44M
Avg Institutional Trade (30 D):	$2.09M
Avg Institutional Trade (90 D):	$2.62M
Avg Institutional Trade Volume:	.13M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.45M
Avg Closing Trade (30 D):	$2.32M
Avg Closing Trade (90 D):	$3.42M
Avg Closing Volume:	197.54K

News

May 23, 2026 @ 10:13 PM Why a Biotech Fund Opened a New $6 Million Positio... Source: Jonathan Ponciano

May 14, 2026 @ 2:55 PM "Cold" Solid Tumors Become the Proving Ground for ... Source: World Street Intelligence News Commentary

Apr 12, 2026 @ 1:13 PM Vir Biotechnology (VIR) CEO Sells 73,000 Shares fo... Source: Cory Renauer

Feb 24, 2026 @ 1:31 PM Stock Market Today: S&P 500 Futures Slip As Dow, N... Source: Rishabh Mishra

Dec 7, 2025 @ 7:25 AM Is Alnylam Pharmaceuticals a Millionaire Maker? Source: Keith Speights

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-1.76	$.48	$-.85
Diluted EPS	$-1.76	$.47	$-.85
Revenue	$303.23M	$238.95M	$-.03M
Gross Profit
Net Income / Loss	$-251.68M	$80.08M	$-125.7M
Operating Income / Loss	$-280.19M	$73.47M	$-132.29M
Cost of Revenue	$.02M	$M	$M
Net Cash Flow	$-18.68M	$4.56M	$41.97M
PE Ratio